Cargando…
Natural history of prostate cancer on active surveillance: stratification by MRI using the PRECISE recommendations in a UK cohort
OBJECTIVES: The PRECISE recommendations for magnetic resonance imaging (MRI) in patients on active surveillance (AS) for prostate cancer (PCa) include repeated measurement of each lesion, and attribution of a PRECISE radiological progression score for the likelihood of clinically significant change...
Autores principales: | Giganti, Francesco, Stabile, Armando, Stavrinides, Vasilis, Osinibi, Elizabeth, Retter, Adam, Orczyk, Clément, Panebianco, Valeria, Trock, Bruce J., Freeman, Alex, Haider, Aiman, Punwani, Shonit, Allen, Clare, Kirkham, Alex, Emberton, Mark, Moore, Caroline M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7880925/ https://www.ncbi.nlm.nih.gov/pubmed/33000302 http://dx.doi.org/10.1007/s00330-020-07256-z |
Ejemplares similares
-
Interobserver reproducibility of the PRECISE scoring system for prostate MRI on active surveillance: results from a two-centre pilot study
por: Giganti, Francesco, et al.
Publicado: (2019) -
Inter-reader agreement of the PI-QUAL score for prostate MRI quality in the NeuroSAFE PROOF trial
por: Giganti, Francesco, et al.
Publicado: (2021) -
Five-year Outcomes of Magnetic Resonance Imaging–based Active Surveillance for Prostate Cancer: A Large Cohort Study [Image: see text] ()
por: Stavrinides, Vasilis, et al.
Publicado: (2020) -
Tumour growth rates of prostate cancer during active surveillance: is there a difference between MRI-visible low and intermediate-risk disease?
por: Giganti, Francesco, et al.
Publicado: (2022) -
MRI findings in men on active surveillance for prostate cancer: does dutasteride make MRI visible lesions less conspicuous? Results from a placebo-controlled, randomised clinical trial
por: Giganti, Francesco, et al.
Publicado: (2017)